Yahoo Web Search

Search results

1. • 

     Is Amgen Stock a Buy?

     Motley Fool via Yahoo Finance· 5 days ago

     The results included a boost from its recent acquisition of Horizon Therapeutics, which closed in October. But Amgen's top-selling drug of last year, ...

2. • 

     Remicade and interactions: Other drugs, alcohol, and more

     Medical News Today· 4 days ago

     Before you start treatment with Remicade, tell your doctor and pharmacist which prescription,...

3. • 

     Is Pfizer Stock A Sell As Shares Hit A Fresh Low Amid The Search For Its Next Big Break?

     Investor's Business Daily· 6 days ago

     Prevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...

4. • Indemnity Ins. Co. of N. Am. v. Unitrans Int'l Corp. | New York Law Journal

     Law.com· 4 days ago

     Indemnity Insurance Company of North America (“Indemnity”) appeals from the district court’s grant of summary judgment in favor of Unitrans International Corporation (“Unitrans”) on Indemnity ...

5. • Stages of ankylosing spondylitis: Symptoms and when to call a doctor

     Medical News Today· 6 days ago

     There are three ankylosing spondylitis stages — early, progressive, and late. Getting treatment earlier can help reduce complications. Symptoms of the early stage may include lower back stiffness ...

6. • Meet The Billionaire-Owned Company Making Injectors For Blockbuster Drugs Like Ozempic

     Forbes· 4 days ago

     The runaway success of weight loss drugs took the markets by storm last year, spurring huge stock gains for drugmakers like Novo Nordisk, which makes Wegovy and Ozempic. Most patients take them ...

7. • Looking At Amgen's Recent Unusual Options Activity - Amgen (NASDAQ:AMGN)

     Benzinga· 4 days ago

     Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...

8. • Sumitomo Life Insurance Co. Decreases Stake in Biogen Inc. (NASDAQ:BIIB)

     ETF DAILY NEWS· 1 day ago

     Sumitomo Life Insurance Co. cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities ...

9. • WCM Investment Management LLC Takes $336,000 Position in Amgen Inc. (NASDAQ:AMGN)

     ETF DAILY NEWS· 1 day ago

     WCM Investment Management LLC acquired a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...

10. • FY2024 EPS Estimates for Biogen Inc. Decreased by Analyst (NASDAQ:BIIB)

      ETF DAILY NEWS· 7 days ago

      Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Biogen in a research note issued to investors ...